Humana Inc (HUM) Financial Statements

Humana's revenue growth of 11.3% YoY is a positive indicator, showing the company is expanding its top line. However, the quality of its financials is unfavourable when assessed against the framework's thresholds. Profitability is critically low, with a profit margin of only 0.9% and an operating margin of 2.1%. This suggests very little earnings power from its revenue base. Free cash flow generation is also weak, with a 1.9% FCF yield implying minimal cash returned to shareholders relative to the company's market value. For context, the framework looks for FCF margins above 10-15%, which Humana is not achieving. The balance sheet shows moderate leverage with a Debt/Equity ratio of 0.72, which is manageable but not the substantial net cash position favoured by the framework. The most concerning metric is the Return on Equity (ROE) of 6.7%, which is far below the framework's high-quality threshold of 15-20% for Return on Invested Capital (ROIC). This indicates the company is not generating attractive returns on shareholder capital. In summary, while growth is present, the financial quality is undermined by thin margins, weak cash flow, and poor returns on capital, which are key pillars for a value investor. Analysis based on data as of 2024-05-15.